Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial

This is a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial examining semaglutide's effects on cardiac structure and function in heart failure with preserved ejection fraction and obesity. No results are provided in the available context.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.